Company Overview

Company name: Kaleidoscope Labs
Description: Provider of CBD based capsules intended to nurture body and mind. The company’s offerings include wake, sleep, sooth, glow and boost capsules made using microencapsulation technology to increase the bioavailability, enabling consumers to be more effective in daily life.
Year founded: 2019
Parent company:
Industry: Healthcare | Group: | Code:
City: New York
State: New York
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $4 million of Seed funding in a deal led by RRE Ventures on July 8, 2019, putting the company’s pre-money valuation at $8 million. Barry Rosenstein also participated in the round. The funds will be used for expansion of the brand, furthering product efficacy, and support their nonprofit arm, Kaleidoscope Gives Foundation that provides grants to a variety of causes in the cannabis industry.
Number of active investors:
Profile last updated:
Last known valuation: 12.00
Last known valuation date: 08-Jul-2019